|Image via Wikipedia|
The FDA has received a report of a patient with MS who died within 24 hours of taking the first dose of Gilenya.
FDA has said it cannot conclude whether the drug resulted in the patient's death, but was evaluating the case.
The patient was also treated with two other drugs, and had completed 6 hours of monitoring after the first Gilenya dose without incident.
The drug's maker said it was investigating whether Gilenya caused the death of a 59-year-old patient who had just started therapy with the drug.
Our 12/13/2011 post is here: http://ageorgialawyer.blogspot.com/2011/12/death-involving-patient-taking-gilenya.html